Seroprevalence of SARS-CoV-2 anti-spike IgG antibody among COVID-19 vaccinated individuals residing in Surabaya, East Java, Indonesia

BACKGROUND: To limit the SARS-CoV-2 transmission, the Indonesian government launched a COVID-19 vaccination program in January 2021. Studies on the clinical treatment and implementation of COVID-19 vaccination have shown promising results; however, it is necessary to estimate the effectiveness of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Megasari, Ni Luh Ayu, Yamani, Laura Navika, Juniastuti, Juniastuti, Lusida, Maria Inge, Mori, Yasuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538276/
https://www.ncbi.nlm.nih.gov/pubmed/37780375
http://dx.doi.org/10.7717/peerj.16142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538276/
https://www.ncbi.nlm.nih.gov/pubmed/37780375
http://dx.doi.org/10.7717/peerj.16142

Ejemplares similares